Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Goossens

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Blood Cancer Discovery|November 12, 2020
Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemiaJuliette Roels, Morgan Thénoz, Bronisława Szarzyńska, et al.
Science Advances|July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibitionCarolina Nunes, Lisa Depestel, Liselot Mus, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Blood|May 6, 2020
The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1Catherine L Carmichael, Jueqiong Wang, Thao Nguyen, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Blood Cancer Discovery|November 12, 2020
Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemiaJuliette Roels, Morgan Thénoz, Bronisława Szarzyńska, et al.
Science Advances|July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibitionCarolina Nunes, Lisa Depestel, Liselot Mus, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Blood|May 6, 2020
The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1Catherine L Carmichael, Jueqiong Wang, Thao Nguyen, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Pageof 10